Manzoni, Paolo <br/><br/>
Outcomes of Infants Receiving Palivizumab Prophylaxis for Respiratory Syncytial Virus in Canada and Italy: An International, Prospective Cohort Study.  [electronic resource] 

 -  The Pediatric infectious disease journal  01 2017 
 - 2-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-0987 
<br/><br/><label>Standard No.: </label>10.1097/INF.0000000000001340  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--administration & dosage<br/>Canada--epidemiology<br/>Hospitalization<br/>Humans<br/>Infant, Newborn<br/>Italy--epidemiology<br/>Palivizumab--administration & dosage<br/>Prospective Studies<br/>Respiratory Syncytial Virus Infections--drug therapy<br/>Respiratory Syncytial Virus, Human<br/>Risk Factors